Structural basis for viral late-domain binding to Alix

Nature Structural and Molecular Biology

Volumn 14, Issue 3, 2007, Pages 194-199

  Lee, Sangho ^a   Joshi, Anjali ^b   Nagashima, Kunio ^b   Freed, Eric O ^b   Hurley, James H ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PROTEIN ALIX; UNCLASSIFIED DRUG;

ALPHA HELIX; ARTICLE; CONTROLLED STUDY; ENDOSOME; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROPHOBICITY; LYSOSOME; MEMBRANE TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN STRUCTURE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; BINDING SITES; CALCIUM-BINDING PROTEINS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CRYSTALLOGRAPHY, X-RAY; GENE PRODUCTS, GAG; HELA CELLS; HIV-1; HUMANS; HYDROPHOBICITY; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHENYLALANINE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33847638834     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb1203     Document Type: Article

References (45)

1. Freed, E.O. HIV-1 Gag proteins: diverse functions in the virus life cycle. Virology 251, 1-15 (1998).
2. Bieniasz, P.D. Late budding domains and host proteins in enveloped virus release. Virology 344, 55-63 (2006).
3. Demirov, D.G. & Freed, E.O. Retrovirus budding. Virus Res. 106, 87-102 (2004).
4. Morita, E. & Sundquist, W.I. Retrovirus budding. Annu. Rev. Cell Dev. Biol. 20, 395-425 (2004).
5. Demirov, D.G., Ono, A., Orenstein, J.M. & Freed, E.O. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc. Natl. Acad. Sci. USA 99, 955-960 (2002).
6. Garrus, J.E. et al. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107, 55-65 (2001).
7. Goila-Gaur, R., Demirov, D.G., Orenstein, J.M., Ono, A. & Freed, E.O. Defects in human immunodeficiency virus budding and endosomal sorting induced by TSG101 overexpression. J. Virol. 77, 6507-6519 (2003).
8. Martin-Serrano, J., Zang, T. & Bieniasz, P.D. HIV-I and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat. Med. 7, 1313-1319 (2001).
9. Martin-Serrano, J., Zang, T. & Bieniasz, P.D. Role of ESCRT-I in retroviral budding. J. Virol. 77, 4794-4804 (2003).
10. VerPlank, L. et al. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc. Natl. Acad. Sci. USA 98, 7724-7729 (2001).
11. Yuan, B., Li, X.Q. & Goff, S.P. Mutations altering the Moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle. EMBO J. 18, 4700-4710 (1999).
12. Kikonyogo, A. et al. Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells. Proc. Natl. Acad. Sci. USA 98, 11199-11204 (2001).
13. Martin-Serrano, J., Eastman, S.W., Chung, W. & Bieniasz, P.D. HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway. J. Cell Biol. 168, 89-101 (2005).
14. Strack, B., Calistri, A., Accola, M.A., Palu, G. & Gottlinger, H.G. A role for ubiquitin ligase recruitment in retrovirus release. Proc. Natl. Acad. Sci. USA 97, 13063-13068 (2000).
15. 2+-dependent reaction. J. Biol. Chem. 274, 1533-1540 (1999).
16. Missotten, M., Nichols, A., Rieger, K. & Sadoul, R. Alix, a novel mouse protein undergoing calcium-dependent interaction with the apoptosis-linked-gene 2 (ALG-2) protein. Cell Death Differ. 6, 124-129 (1999).
17. Chen, C., Vincent, O., Jin, J., Weisz, O.A. & Montelaro, R.C. Functions of early (AP-2) and late (AIP1/ALIX) endocytic proteins in equine infectious anemia virus budding. J. Biol. Chem. 280, 40474-40480 (2005).
18. Strack, B., Calistri, A., Craig, S., Popova, E. & Gottlinger, H.G. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 114, 689-699 (2003).
19. von Schwedler, U.K. et al. The protein network of HIV budding. Cell 114, 701-713 (2003).
20. Odorizzi, G. The multiple personalities of Alix. J. Cell Sci. 119, 3025-3032 (2006).
21. Sadoul, R. Do Alix and ALg-2 really control endosomes for better or for worse? Biol. Cell 98, 69-77 (2006).
22. Pan, S. et al. Involvement of the adaptor protein alix in actin cytoskeleton assembly. J. Biol. Chem. 281, 34640-34650 (2006).
23. Kim, J. et al. Structural basis for endosomal targeting by the Bro1 domain. Dev. Cell 8, 937-947 (2005).
24. Munshi, U., Kim, J., Nagashima, K., Hurley, J.H. & Freed, E.O. An Alix fragment potently inhibits HIV-1 budding: characterization of binding to retroviral YPXL late domains. J. Biol. Chem. published online 8 December 2006 (doi:10.1074/jbc.M607489200).
25. Bowers, K. & Stevens, T.H. Protein transport from the late Golgi to the vacuole in the yeast Saccharomyces cerevisiae. Biochim. Biophys. Acta 1744, 438-454 (2005).
26. Hurley, J.H. & Emr, S.D. The ESCRTcomplexes: structure and mechanism of a membrane-trafficking network. Annu. Rev. Biophys. Biomol. Struct. 35, 277-298 (2006).
27. Babst, M. Protein's final ESCRT. Traffic 6, 2-9 (2005).
28. van der Goot, F.G. & Gruenberg, J. Intra-endosomal membrane traffic. Trends Cell Biol. 16, 514-521 (2006).
29. Slagsvold, T., Pattni, K., Malerod, L. & Stenmark, H. Endosomal and non-endosomal functions of ESCRT proteins. Trends Cell Biol. 16, 317-326 (2006).
30. Chen, B., Borinstein, S.C., Gillis, J., Sykes, V.W. & Bogler, O. The glioma-associated protein SETA interacts with AIP1/Alix and AZIG-2 and modulates apoptosis in astrocytes. J. Biol. Chem. 275, 19275-19281 (2000).
31. Chatellard-Causse, C. et al. Alix (ALG-2-interacting protein X), a protein involved in apoptosis, binds to endophilins and induces cytoplasmic vacuolization. J. Biol. Chem. 277, 29108-29115 (2002).
32. Matsuo, H. et al. Role of LBPA and Alix in multivesicular liposome formation and endosome organization. Science 303, 531-534 (2004).
33. Fossen, T. et al. Solution structure of the human immunodeficiency virus type 1 p6 protein. J. Biol. Chem. 280, 42515-42527 (2005).
34. Hurley, J.H. Leucine in the sky with diamonds. Structure 11, 1192-1193 (2003).
35. Hoellerer, M.K. et al. Molecular recognition of paxillin LD motifs by the focal adhesion targeting domain. Structure 11, 1207-1217 (2003).
36. Sheffield, P., Garrard, S. & Derewenda, Z. Overcoming expression and purification problems of RhoGDI using a family of "parallel" expression vectors. Protein Expr. Purif. 15, 34-39 (1999).
37. Terwilliger, T.C. & Berendzen, J. Automated MAD and MIR structure solution. Acta Crystallogr. D Biol. Crystallogr. 55, 849-861 (1999).
38. Terwilliger, T.C. Maximum-likelihood density modification. Acta Crystallogr. D Biol. Crystallogr. 56, 965-972 (2000).
39. Jones, T.A., Zou, J.Y., Cowan, S.W. & Kjeldgaard, M. Improved methods for building protein models in electron-density maps and the location of errors in these models. Acta Crystallogr. A 47, 110-119 (1991).
40. Brunger, A.T. et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54, 905-921 (1998).
41. Winn, M.D., Isupov, M.N. & Murshudov, G.N. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr. D Biol. Crystallogr. 57, 122-133 (2001).
42. : DeLano, W.L. The PyMOL Molecular Graphics System (DeLano Scientific, San Carlos, California, USA, 2002).
43. Freed, E.O. & Martin, M.A. Evidence for a functional interaction between the V1/V2 and 4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120. J. Virol. 68, 2503-2512 (1994).
44. Willey, R.L., Bonifacino, J.S., Potts, B.J., Martin, M.A. & Klausner, R.D. Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. Proc. Natl. Acad. Sci. USA 85, 9580-9584 (1988).
45. Freed, E.O., Orenstein, J.M., Buckler-White, A.J. & Martin, M.A. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J. Virol. 68, 5311-5320 (1994).